314 related articles for article (PubMed ID: 20368690)
1. Analgesic α-conotoxins Vc1.1 and RgIA inhibit N-type calcium channels in sensory neurons of α9 nicotinic receptor knockout mice.
Callaghan B; Adams DJ
Channels (Austin); 2010; 4(1):51-4. PubMed ID: 20368690
[TBL] [Abstract][Full Text] [Related]
2. Analgesic alpha-conotoxins Vc1.1 and Rg1A inhibit N-type calcium channels in rat sensory neurons via GABAB receptor activation.
Callaghan B; Haythornthwaite A; Berecki G; Clark RJ; Craik DJ; Adams DJ
J Neurosci; 2008 Oct; 28(43):10943-51. PubMed ID: 18945902
[TBL] [Abstract][Full Text] [Related]
3. γ-Aminobutyric acid type B (GABAB) receptor expression is needed for inhibition of N-type (Cav2.2) calcium channels by analgesic α-conotoxins.
Cuny H; de Faoite A; Huynh TG; Yasuda T; Berecki G; Adams DJ
J Biol Chem; 2012 Jul; 287(28):23948-57. PubMed ID: 22613715
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of conotoxin inhibition of N-type (Ca(v)2.2) calcium channels.
Adams DJ; Berecki G
Biochim Biophys Acta; 2013 Jul; 1828(7):1619-28. PubMed ID: 23380425
[TBL] [Abstract][Full Text] [Related]
5. A novel mechanism of inhibition of high-voltage activated calcium channels by α-conotoxins contributes to relief of nerve injury-induced neuropathic pain.
Klimis H; Adams DJ; Callaghan B; Nevin S; Alewood PF; Vaughan CW; Mozar CA; Christie MJ
Pain; 2011 Feb; 152(2):259-266. PubMed ID: 20889259
[TBL] [Abstract][Full Text] [Related]
6. Analgesic conotoxins: block and G protein-coupled receptor modulation of N-type (Ca(V) 2.2) calcium channels.
Adams DJ; Callaghan B; Berecki G
Br J Pharmacol; 2012 May; 166(2):486-500. PubMed ID: 22091786
[TBL] [Abstract][Full Text] [Related]
7. Structure-Activity Studies Reveal the Molecular Basis for GABA
Sadeghi M; Carstens BB; Callaghan BP; Daniel JT; Tae HS; O'Donnell T; Castro J; Brierley SM; Adams DJ; Craik DJ; Clark RJ
ACS Chem Biol; 2018 Jun; 13(6):1577-1587. PubMed ID: 29746088
[TBL] [Abstract][Full Text] [Related]
8. α-Conotoxin Vc1.1 inhibits human dorsal root ganglion neuroexcitability and mouse colonic nociception via GABA
Castro J; Harrington AM; Garcia-Caraballo S; Maddern J; Grundy L; Zhang J; Page G; Miller PE; Craik DJ; Adams DJ; Brierley SM
Gut; 2017 Jun; 66(6):1083-1094. PubMed ID: 26887818
[TBL] [Abstract][Full Text] [Related]
9. Presence of multiple binding sites on α9α10 nAChR receptors alludes to stoichiometric-dependent action of the α-conotoxin, Vc1.1.
Indurthi DC; Pera E; Kim HL; Chu C; McLeod MD; McIntosh JM; Absalom NL; Chebib M
Biochem Pharmacol; 2014 May; 89(1):131-40. PubMed ID: 24548457
[TBL] [Abstract][Full Text] [Related]
10. Structure and activity of alpha-conotoxin PeIA at nicotinic acetylcholine receptor subtypes and GABA(B) receptor-coupled N-type calcium channels.
Daly NL; Callaghan B; Clark RJ; Nevin ST; Adams DJ; Craik DJ
J Biol Chem; 2011 Mar; 286(12):10233-7. PubMed ID: 21252227
[TBL] [Abstract][Full Text] [Related]
11. Interaction of rat α9α10 nicotinic acetylcholine receptor with α-conotoxin RgIA and Vc1.1: Insights from docking, molecular dynamics and binding free energy contributions.
Li R; Li X; Jiang J; Tian Y; Liu D; Zhangsun D; Fu Y; Wu Y; Luo S
J Mol Graph Model; 2019 Nov; 92():55-64. PubMed ID: 31330438
[TBL] [Abstract][Full Text] [Related]
12. Targeting of N-Type Calcium Channels via GABA
Cai F; Xu N; Liu Z; Ding R; Yu S; Dong M; Wang S; Shen J; Tae HS; Adams DJ; Zhang X; Dai Q
J Med Chem; 2018 Nov; 61(22):10198-10205. PubMed ID: 30358401
[TBL] [Abstract][Full Text] [Related]
13. Analgesic α-conotoxins modulate native and recombinant GIRK1/2 channels via activation of GABA
Bony AR; McArthur JR; Finol-Urdaneta RK; Adams DJ
Br J Pharmacol; 2022 Jan; 179(1):179-198. PubMed ID: 34599513
[TBL] [Abstract][Full Text] [Related]
14. Conotoxin Interactions with α9α10-nAChRs: Is the α9α10-Nicotinic Acetylcholine Receptor an Important Therapeutic Target for Pain Management?
Mohammadi SA; Christie MJ
Toxins (Basel); 2015 Sep; 7(10):3916-32. PubMed ID: 26426047
[TBL] [Abstract][Full Text] [Related]
15. Alpha9 nicotinic acetylcholine receptors and the treatment of pain.
McIntosh JM; Absalom N; Chebib M; Elgoyhen AB; Vincler M
Biochem Pharmacol; 2009 Oct; 78(7):693-702. PubMed ID: 19477168
[TBL] [Abstract][Full Text] [Related]
16. Novel mechanism of voltage-gated N-type (Cav2.2) calcium channel inhibition revealed through α-conotoxin Vc1.1 activation of the GABA(B) receptor.
Huynh TG; Cuny H; Slesinger PA; Adams DJ
Mol Pharmacol; 2015 Feb; 87(2):240-50. PubMed ID: 25425625
[TBL] [Abstract][Full Text] [Related]
17. ɑO-Conotoxin GeXIVA isomers modulate N-type calcium (Ca
Yousuf A; Wu X; Bony AR; Sadeghi M; Huang YH; Craik DJ; Adams DJ
J Neurochem; 2022 Jan; 160(2):154-171. PubMed ID: 34738241
[TBL] [Abstract][Full Text] [Related]
18. Analgesic α-Conotoxin Binding Site on the Human GABA
Bony AR; McArthur JR; Komori A; Wong AR; Hung A; Adams DJ
Mol Pharmacol; 2022 Oct; 102(4):196-208. PubMed ID: 35944919
[TBL] [Abstract][Full Text] [Related]
19. Effects of cyclization on stability, structure, and activity of α-conotoxin RgIA at the α9α10 nicotinic acetylcholine receptor and GABA(B) receptor.
Halai R; Callaghan B; Daly NL; Clark RJ; Adams DJ; Craik DJ
J Med Chem; 2011 Oct; 54(19):6984-92. PubMed ID: 21888386
[TBL] [Abstract][Full Text] [Related]
20. A novel α-conopeptide Eu1.6 inhibits N-type (Ca
Liu Z; Bartels P; Sadeghi M; Du T; Dai Q; Zhu C; Yu S; Wang S; Dong M; Sun T; Guo J; Peng S; Jiang L; Adams DJ; Dai Q
Sci Rep; 2018 Jan; 8(1):1004. PubMed ID: 29343689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
